Farther Finance Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $111K | Sell |
6,622
-118
| -2% | -$1.98K | ﹤0.01% | 1703 |
|
|
2025
Q1 | $103K | Buy |
6,740
+148
| +2% | +$2.26K | ﹤0.01% | 1533 |
|
|
2024
Q4 | $145K | Buy |
6,592
+2,054
| +45% | +$45.3K | 0.01% | 1146 |
|
|
2024
Q3 | $81.8K | Buy |
4,538
+3,323
| +273% | +$59.9K | ﹤0.01% | 1399 |
|
|
2024
Q2 | $19.9K | Sell |
1,215
-160
| -12% | -$2.61K | ﹤0.01% | 1778 |
|
|
2024
Q1 | $19.1K | Buy |
1,375
+9
| +0.7% | +$125 | ﹤0.01% | 1507 |
|
|
2023
Q4 | $14.3K | Buy |
1,366
+963
| +239% | +$10.1K | ﹤0.01% | 1454 |
|
|
2023
Q3 | $4.11K | Buy |
403
+52
| +15% | +$530 | ﹤0.01% | 1583 |
|
|
2023
Q2 | $2.64K | Buy |
351
+156
| +80% | +$1.18K | ﹤0.01% | 1658 |
|
|
2023
Q1 | $1.73K | Hold |
195
| – | – | ﹤0.01% | 1687 |
|
|
2022
Q4 | $1.78K | Buy |
+195
| New | +$1.78K | ﹤0.01% | 1493 |
|